BNGO - Company ID 0001411690
The table below shows Bionano Genomics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $28.51M | $30.78M | $36.12M | $27.80M | $17.98M | $8.50M |
| Cost of revenue | $15.32M | $30.40M | $26.55M | $21.86M | $14.11M | $5.73M |
| Gross profit | - | - | - | - | - | - |
| R&D | $11.37M | $24.80M | $54.03M | $49.05M | $22.48M | $10.26M |
| SG&A |
Bionano Genomics, Inc. reported annual revenue of $28.51M for fiscal year 2025. That is down 7.4% from $30.78M in fiscal 2024. Over the 9 fiscal years shown, annual revenue grew from $9.51M (FY 2017) to $28.51M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $35.15M |
| $51.85M |
| $92.76M |
| $88.60M |
| $58.49M |
| $31.07M |
| Operating income | -$33.34M | -$103.98M | -$215.25M | -$131.70M | -$77.10M | -$38.55M |
| Income tax | $67.00K | $33.00K | $62.00K | $1.88M | -$5.72M | $29.00K |
| Net income | -$26.39M | -$112.02M | -$232.49M | -$132.60M | -$72.44M | -$41.11M |
| EPS (diluted) | -$4.85 | -$88.13 | -$408.60 | -$4.58 | -$0.26 | - |